Book a demo

Chemical intelligence powered by cypris.ai

Quercitrin

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one · also: Thujin, Usaf cf-2, Quercetrin, Quercimelin, quericitrin, Quercitroside

FormulaC21H20O11
Mol. weight448.38
PubChem CID5280459
InChIKeyOXGUCUVFOIWWQJ-HQBVPOQASA-N
SMILESC[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O
7,657Patents
419Research papers
814Patents - last 3 years
19Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Symrise AG384
2Nicoventures Trading Ltd289
3L'Oréal SA77
4Beiersdorf AG62
5Teva Pharmaceutical Industries Ltd60
6Cargill Inc45
7Sumitomo Rubber Industries Ltd41
8Kose Corp39
9Suntory Holdings Ltd36
10Kao Corp35

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations3,820
2A61PTherapeutic activity (drug indications)2,232
3A61QCosmetics, personal care1,451
4A23LFoods and beverages (general)1,249
5A23VFoods, foodstuffs - indexing scheme854
6G01NInvestigating / analysing materials391
7A24B350
8C07DHeterocyclic compounds329
9Y02AClimate change adaptation289
10A01NPreservation of bodies; biocides; pest repellents268

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Most-cited patents

Patents ranked by forward citations reveal the foundational inventions the field continues to build on.

TitleYearAssigneeCited by
Application of quercitrin in preparation of human gamma delta T cell proliferator201497 HOSPITAL OF PEOPLE'S LIBERATION ARMY5
COSMETIC COMPOSITION COMPRISING QUERCITRIN AND/OR MYRICITRIN AS ACTIVE INGREDIENTS2010COREANA COSMETICS CO., LTD.5
Process of isolating quercitrin1950BOOTH ALBERT N5
A method of extracting quercitrin and Bergenin from ardisia japonica2018HUNAN AGRICULTURAL UNIVERSITY3
A method of extracting ardisin and quercitrin from ardisia japonica2018HUNAN AGRICULTURAL UNIVERSITY3

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Aldose Reductase and Taurine2
2Bone Tissue Engineering Materials1
3Chromatography in Natural Products1
4Essential Oils and Antimicrobial Activity1
5Free Radicals and Antioxidants1
6Medicinal Plants and Bioactive Compounds1
7Microbial Metabolites in Food Biotechnology1
8Mosquito-borne diseases and control1
9Natural product bioactivities and synthesis1
10Plant Toxicity and Pharmacological Properties1

Technology trend analysis

Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.

See Cypris in action

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Antonio ZarzueloUniversidad de Granada8
2Edmund MaserPhilipps University of Marburg6
3Aimin WangGuiyang Medical University5
4Arnold VlietinckUniversity of Antwerp4
5Bartira Rossi‐BergmannUniversidade Federal do Rio de Janeiro4
6Dirk Vanden BergheUniversity of Antwerp3
7Dongmei WangNorthwest A&F University4
8Fermín Sánchez de MedinaUniversidad de Granada4
9Jairo Kenupp BastosUniversidade de São Paulo4
10Joana Maria RamisResearch Institute of Health Sciences4

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and structure of Quercitrin?

Quercitrin has the molecular formula C21H20O11 with a molecular weight of 448.38 g/mol. Its canonical IUPAC name is 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one, and it is also known by numerous synonyms including Quercetin-3-rhamnoside and Thujin.

Which companies hold the most patents related to Quercitrin?

The leading patent assignees for Quercitrin are Symrise AG with 384 patents, Nicoventures Trading Ltd with 289 patents, L'Oréal SA with 77 patents, Beiersdorf AG with 62 patents, and Teva Pharmaceutical Industries Ltd with 60 patents.

What are the main research topics associated with Quercitrin in published literature?

Prominent research areas include anti-inflammatory effects and antioxidant activities. A highly-cited 2005 paper demonstrated that in vivo quercitrin anti-inflammatory effects involve release of quercetin and inhibition of the NF-κB pathway. Another notable 2019 paper assessed quercetin and quercitrin's ability to attenuate inflammatory response and oxidative stress in LPS-induced cells. Additional research has explored quercitrin as a dietary source from Tartary Buckwheat and its antidiarrhoeic activity.

What are the primary patent classification areas for Quercitrin inventions?

The largest patent classification areas are A61K (pharmaceutical preparations) with 3,820 patents, A61P (specific therapeutic activity of chemical compounds) with 2,232 patents, A61Q (cosmetics and personal care) with 1,451 patents, and A23L (food preparation and preservation) with 1,249 patents. These classifications reflect applications in pharmaceuticals, cosmetics, and food products.

Who are the most prolific authors publishing research on Quercitrin?

The leading researchers include Antonio Zarzuelo from Universidad de Granada with 8 papers, Edmund Maser from Philipps University of Marburg with 6 papers, and Aimin Wang from Guiyang Medical University with 5 papers. Other active researchers include Arnold Vlietinck and Bartira Rossi‐Bergmann, each with 4 papers.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial